Clinical Trial Update: A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401. [Phase 4]

View source ↗

Summary

A Phase 4 master protocol trial evaluating ZYNRELEF (HTX-011) across multiple surgeries in analgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia

Drugs mentioned

• ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 4 | Status: UNKNOWN